<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-08-28 13:03:30Medicine Immune system Monoclonal antibodies Biotechnology Glycoproteins Monoclonal antibody therapy Hybridoma technology Bi-specific T-cell engager Antigen Anatomy Biology Immunology |
Add to Reading List |
CHAPTER 1 AL ANTIBODY-MEDIATED DRUG | Immunotherapy: Big Pharma’s Seductive Embrace The advent of the first wave of checkpoint inhibitors has the oncology community believing that immunotherapy will be foundational, in the same way that combination chemothDocID: 1grCr - View Document |
| Immunotherapy: Big Pharma’s Seductive Embrace The advent of the first wave of checkpoint inhibitors has the oncology community believing that immunotherapy will be foundational, in the same way that combination chemothDocID: 1gf3m - View Document |
| PDF DocumentDocID: 1aD8f - View Document |
| A novel immunotherapy technique to treat patients with osteosarcoma and neuroblastomaDocID: 12GMO - View Document |
| U N I T 5 : T H E L A N G U A G E P O L I T I C SDocID: 101CZ - View Document |